Korro Bio KRRO
NASDAQ KRRO
$14.41 -1.32 (-8.39%)
At close: Nov 11, 2026 · 4:00 PM EST

Korro Bio (KRRO) Preferred Stock Liabilities (2018 - 2022)

Updated

Korro Bio's Preferred Stock Liabilities was $163.86 million in Q4 2022, unchanged from $163.86 million a year earlier.

Analysis

Korro Bio (KRRO) Preferred Stock Liabilities (2018 - 2022) Analysis & Trends

From Q4 2018 onward, Korro Bio has reported Preferred Stock Liabilities for 4 quarters.

  • Preferred Stock Liabilities shows a five-year compound annual growth rate of 51.1% (FY2017 to FY2022).
  • In earlier years, Preferred Stock Liabilities was $163.86 million in FY2021 and $84.94 million in FY2018 (+308.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Korro Bio 281.05 Mn -128.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 163.86 Mn
Dec 31, 2021 163.86 Mn
Sep 30, 2019 147.90 Mn
Dec 31, 2018 84.94 Mn
API Access

Korro Bio Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=KRRO&period=max&api_key=YOUR_API_KEY